文献速递甲状腺核医学

甲状腺结节风险分层中省略甲状腺显像会增加假阳性可疑病变率

Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions.
PubMed 文献 · J Nucl Med · 2018-08-10

研究评估615个高功能甲状腺结节(HTN)在TIRADS模型下的分类,发现超过80%的HTN被归为TIRADS 4A或更高,会导致细针穿刺推荐;而手术亚组中所有结节均为良性。结论认为将甲状腺显像整合入TIRADS模型对避免不必要的细针穿刺和甲状腺手术至关重要。

要点

  • 超过80%的高功能甲状腺结节被TIRADS归为4A或更高,会触发细针穿刺推荐。
  • 在117例已有甲状腺功能亢进实验室指标的高功能结节中,81.2%被归为TIRADS 4A或更高。
  • 手术亚组中所有结节均为良性,证实高功能结节对排除恶性有高阴性预测值。

核心结论

  • 将甲状腺显像整合入TIRADS模型对于防止不必要的细针穿刺和甲状腺手术至关重要。

研究设计与样本

  • 评估了582例患者(442名女性,年龄57.7±13.2岁;140名男性,年龄60.1±12.7岁)中经99mTc-高锝酸盐或123I显像检测的615个高功能甲状腺结节(最大直径23.2±10.0 mm)。
  • 在评估显像表现前,所有结节均前瞻性接受超声分析,采用Kwak等引用的TIRADS模型,其中TIRADS 4A或更高推荐细针穿刺。
  • 还研究了2个亚组:42个有可用组织学的结节和117例亚临床或临床甲状腺功能亢进患者。

主要发现

  • 15.9%的结节被分类为TIRADS 3或更低,不到0.1%为TIRADS 5,大多数结节被分类为TIRADS 4A(29.3%)、4B(29.3%)或4C(24.9%)。
  • 超过80%的高功能甲状腺结节被分类为TIRADS 4A或更高,该分级会导致细针穿刺推荐。
  • 在117个已伴有甲状腺功能亢进实验室指标的高功能结节中,81.2%被归类为TIRADS 4A或更高(4A 33.3%;4B 29.9%;4C 17.1%;5 0.9%)。
  • 在接受甲状腺手术的患者亚组中,所有结节均为良性,证实了高功能结节对排除恶性的已知阴性预测值。

关键数值与推荐

  • 采用Kwak等引用的TIRADS模型,TIRADS 4A或更高推荐细针穿刺。
  • 615个高功能结节中,TIRADS 3或更低占15.9%,TIRADS 5占不到0.1%,TIRADS 4A占29.3%,4B占29.3%,4C占24.9%。
  • 117个伴甲状腺功能亢进实验室指标的高功能结节中,TIRADS 4A或更高占81.2%(4A 33.3%;4B 29.9%;4C 17.1%;5 0.9%)。

临床怎么用

  • 原文结论认为将甲状腺显像整合入TIRADS模型对于防止不必要的细针穿刺和甲状腺手术至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thyroid nodules are a common finding, especially in iodine-deficient regions. Ultrasonographic scoring systems such as the Thyroid Imaging Reporting and Data System (TIRADS) are helpful in differentiating between benign and malignant thyroid nodules by offering a risk stratification model. Depending on the constellation or number of suspicious ultrasound features, a fine-needle biopsy is recommended. However, none of the previous TIRADS publications considered the functional status of the nodules. Hyperfunctioning thyroid nodules (HTNs) were presumed to exclude malignancy with a very high negative predictive value. Particularly in regions where the iodine supply is low, most HTNs are seen in patients with normal thyroid-stimulating hormone levels. Therefore, thyroid scintigraphy is essential for the detection of HTNs. We investigated whether TIRADS identifies HTNs as nonsuspicious. Methods: We evaluated 615 HTNs (23.2 ± 10.0 mm in maximum diameter in 582 patients ([442 women, 57.7 ± 13.2 y old, and 140 men, 60.1 ± 12.7 y old) detected by 99mTc-pertechnetate or 123I scintigraphy. Before evaluating the scintigraphic appearance, all nodules were analyzed prospectively with sonography, using the TIRADS model referenced in Kwak et al., wherein fine-needle biopsy is recommended for TIRADS 4A or higher. We also investigated 2 subgroups, 42 nodules with available histology and 117 patients with subclinical or overt hyperthyroidism. Results: Whereas 15.9% of the nodules were classified as TIRADS 3 or lower and less than 0.1% as TIRADS 5, most of the nodules were classified as TIRADS 4A (29.3%), 4B (29.3%), or 4C (24.9%). Altogether, more than 80% of the autonomous thyroid nodules were classified as TIRADS 4A or higher, a grade that would result in a recommendation of fine-needle biopsy. Focusing on those 117 HTNs that were already associated with hyperthyroid laboratory values, the rates were similar: 81.2% were categorized as TIRADS 4A or higher (4A, 33.3%; 4B, 29.9%; 4C,17.1%; 5, 0.9%). In the subgroup of patients who underwent thyroid surgery, all nodules were benign, confirming the known negative predictive value of HTNs with regard to malignancy exclusion. Conclusion: Integration of thyroid scintigraphy into the TIRADS model is essential to prevent unnecessary fine-needle biopsy and thyroid surgery.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Schenke S, Seifert P, Zimny M, et al. Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions. J Nucl Med. 2018. PMID: 30097501. doi:10.2967/jnumed.118.211912

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。